• Roivant Sciences director Melissa B. Epperly sold 17,750 common shares on June 29, 2026, cutting her stake to 16,474 shares.
• She exercised stock options for 17,750 shares at USD 4.46, lifting holdings to 34,224 shares before the sales.
• Shares sold in two blocks at weighted-average prices of USD 34.32 and USD 34.71.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Roivant Sciences Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001807359-26-000010), on July 01, 2026, and is solely responsible for the information contained therein.